Neurocrine Biosciences and Voyager Therapeutics Announce Publication of Phase 1b Trial Results of VY-AADC for Parkinson’s Disease in the Annals of Neurology

March 28, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search